Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin

Abstract. The quality of the blood-brain barrier (BBB), represented mainly by endothelial tight junctions (TJ), is now believed to be dependent on the brain microenvironment and influenced by the basal lamina of the microvessels. In the highly vascularized glioblastoma multiforme (GBM), a dramatic increase in the permeability of blood vessels is observed but the nature of basal lamina involvement remains to be determined. Agrin, a heparan sulfate proteoglycan, is a component of the basal lamina of BBB microvessels, and growing evidence suggests that it may be important for the maintenance of the BBB. In the present study, we provide first evidence that agrin is absent from basal lamina of tumor vessels if the TJ molecules occludin, claudin-5 and claudin-1 were lacking in the endothelial cells. If agrin was expressed, occludin was always localized at the TJ, claudin-5 was frequently detected, whereas claudin-1 was absent from almost all vessels. Furthermore, despite a high variability of vascular phenotypes, the loss of agrin strongly correlated with the expression of tenascin, an extracellular matrix molecule which has been described previously to be absent in mature non-pathological brain tissue and to accumulate in the basal lamina of tumor vessels. These results support the view that in human GBM, BBB breakdown is reflected by the changes of the molecular compositions of both the endothelial TJ and the basal lamina.

[1]  U. J. McMahan,et al.  The agrin hypothesis. , 1990, Cold Spring Harbor symposia on quantitative biology.

[2]  D. Long Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors. , 1970, Journal of neurosurgery.

[3]  M. Werle,et al.  Matrix metalloproteinase-3 removes agrin from synaptic basal lamina. , 2000, Journal of neurobiology.

[4]  S. Kröger Differential Distribution of Agrin Isoforms in the Developing and Adult Avian Retina , 1997, Molecular and Cellular Neuroscience.

[5]  A. Barber,et al.  Agrin accumulates in the brain microvascular basal lamina during development of the blood‐brain barrier , 1997 .

[6]  W. Halfter,et al.  Agrin Binds to β-Amyloid (Aβ), Accelerates Aβ Fibril Formation, and Is Localized to Aβ Deposits in Alzheimer's Disease Brain , 2000, Molecular and Cellular Neuroscience.

[7]  E. Maiorano,et al.  Ultrastructural and morphometric investigation of human brain capillaries in normal and peritumoral tissues. , 1997, Ultrastructural pathology.

[8]  P. Kelly,et al.  Tenascin-C expression in the cyst wall and fluid of human brain tumors correlates with angiogenesis. , 1997, Neurosurgery.

[9]  W. Halfter,et al.  Identification of a Novel Alternatively Spliced Agrin mRNA That Is Preferentially Expressed in Non-neuronal Cells (*) , 1995, The Journal of Biological Chemistry.

[10]  L. Honig,et al.  The developing avian retina expresses agrin isoforms during synaptogenesis. , 1996, Journal of neurobiology.

[11]  J. Bixby,et al.  Agrin orchestrates synaptic differentiation at the vertebrate neuromuscular junction , 1998, Trends in Neurosciences.

[12]  A. Hirano,et al.  Vascular structures in brain tumors. , 1975, Human pathology.

[13]  M. Smith,et al.  Identification of agrin, a synaptic organizing protein from Torpedo electric organ , 1987, The Journal of cell biology.

[14]  M. Rafii,et al.  Agrin in Alzheimer's Disease: Altered Solubility and Abnormal Distribution within Microvasculature and Brain Parenchyma , 1999 .

[15]  Hiroshi Yamamoto,et al.  Induction of various blood‐brain barrier properties in non‐neural endothelial cells by close apposition to co‐cultured astrocytes , 1997, Glia.

[16]  O. Israel,et al.  Quantitative analysis of tight junctions and the uptake of 99mTc in human gliomas. , 1986, Cancer investigation.

[17]  P. Lunardi,et al.  Long-Term Survival in Cerebral Glioblastoma. Case Report and Critical Review of the Literature , 1998, Tumori.

[18]  J. Tonn,et al.  Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas , 1999, International Journal of Developmental Neuroscience.

[19]  K. Nikolics,et al.  Tissue- and age-specific expression patterns of alternatively spliced agrin mRNA transcripts in embryonic rat suggest novel developmental roles , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  D. Zagzag,et al.  Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. , 1996, Cancer research.

[21]  A. Bron,et al.  Ultrastructural morphology and expression of proteoglycans, βig-h3, tenascin-C, fibrillin-1, and fibronectin in bullous keratopathy , 2001, The British journal of ophthalmology.

[22]  W. Risau,et al.  Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes. , 1994, Journal of cell science.

[23]  W. Halfter,et al.  Identification of extracellular matrix ligands for the heparan sulfate proteoglycan agrin. , 1999, Experimental cell research.

[24]  Jae Min Kim,et al.  Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis. , 2000, Surgical neurology.

[25]  S. Liebner,et al.  Correlation of tight junction morphology with the expression of tight junction proteins in blood-brain barrier endothelial cells. , 2000, European journal of cell biology.

[26]  R. Béliveau,et al.  Expression of matrix metalloproteinases and their inhibitors in human brain tumors , 2004, Clinical & Experimental Metastasis.

[27]  V. Tennyson The Fine Structure of the Nervous System. , 1970 .

[28]  P. Jones,et al.  The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.

[29]  S. Brenner,et al.  The structure of the nervous system of the nematode Caenorhabditis elegans. , 1986, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[30]  D. Blake,et al.  The neurobiology of Duchenne muscular dystrophy: learning lessons from muscle? , 2000, Trends in Neurosciences.

[31]  M. Rafii,et al.  Agrin and microvascular damage in Alzheimer's disease , 2000, Neurobiology of Aging.

[32]  S. Liebner,et al.  Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme , 2000, Acta Neuropathologica.

[33]  D. Miller,et al.  Tenascin expression in astrocytomas correlates with angiogenesis. , 1995, Cancer research.

[34]  W. Halfter,et al.  Agrin Is a Heparan Sulfate Proteoglycan (*) , 1995, The Journal of Biological Chemistry.